The ABC-type efflux pump MacAB protects Salmonella enterica serovar typhimurium from oxidative stress

mBio

Volumn 4, Issue 6, 2013, Pages

  Bogomolnaya, Lydia M ^a,b   Andrews, Katharine D ^a   Talamantes, Marissa ^a   Maple, Aimee ^a   Ragoza, Yury ^a   Vazquez Torres, Andres ^c   Andrews Polymenis, Helene ^a  

^a TEXAS A AND M UNIVERSITY SYSTEM   (United States)

^b KAZAN FEDERAL UNIVERSITY   (Russian Federation)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; HYDROGEN PEROXIDE; MACAB PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL DIVISION; CELL GROWTH; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DETOXIFICATION; FEMALE; GROWTH RATE; IN VITRO STUDY; INTESTINE CELL; MACROPHAGE; MOLECULAR DYNAMICS; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; SALMONELLA TYPHIMURIUM; SENSITIVITY ANALYSIS; WILD TYPE;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; COLITIS; CYTOPLASM; DISEASE MODELS, ANIMAL; FEMALE; HYDROGEN PEROXIDE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICROBIAL VIABILITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; SALMONELLA INFECTIONS, ANIMAL; SALMONELLA TYPHIMURIUM; STRESS, PHYSIOLOGICAL;

EID: 84891591361     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00630-13     Document Type: Article

References (85)

1. Santos RL, Zhang S, Tsolis RM, Kingsley RA, Adams LG, Bäumler AJ. 2001. Animal models of Salmonella infections: enteritis versus typhoid fever. Microbes Infect. 3:1335-1344.
2. Aserkoff B, Bennett JV. 1969. Effect of antibiotic therapy in acute salmonellosis on the fecal excretion of salmonellae. N. Engl. J. Med. 281: 636-640.
3. Neill MA, Opal SM, Heelan J, Giusti R, Cassidy JE, White R, Mayer KH. 1991. Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. Ann. Intern. Med. 114:195-199.
4. Nelson JD, Kusmiesz H, Jackson LH, Woodman E. 1980. Treatment of Salmonella gastroenteritis with ampicillin, amoxicillin, or placebo. Pediatrics 65:1125-1130.
5. Sánchez C, García-Restoy E, Garau J, Bella F, Freixas N, Simó M, Lite J, Sánchez P, Espejo E, Cobo E, et al. 1993. Ciprofloxacin and trimethoprim-sulfamethoxazole versus placebo in acute uncomplicated Salmonella enteritis: a double-blind trial. J. Infect. Dis. 168:1304-1307.
6. Sirinavin S, Garner P. 2000. Antibiotics for treating Salmonella gut infections. Cochrane Database Syst. Rev. 2:CD001167. doi:10.1002/ 14651858.CD001167.
7. Barbara G, Stanghellini V, Berti-Ceroni C, De Giorgio R, Salvioli B, Corradi F, Cremon C, Corinaldesi R. 2000. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection. Aliment. Pharmacol. Ther. 14:1127-1131.
8. Hooper DC, Wolfson JS. 1985. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob. Agents Chemother. 28:716-721.
9. McCollister BD, Hoffman M, Husain M, Vázquez-Torres AM. 2011. Nitric oxide protects bacteria from aminoglycosides by blocking the energy-dependent phases of drug uptake. Antimicrob. Agents Chemother. 55:2189-2196.
10. Shaw KJ, Rather PN, Hare RS, Miller GH. 1993. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163.
11. Jaffe A, Chabbert YA, Semonin O. 1982. Role of porin proteins OmpF and OmpC in the permeation of beta-lactams. Antimicrob. Agents Chemother. 22:942-948.
12. Heisig P. 1993. High-level fluoroquinolone resistance in a Salmonella Typhimurium isolate due to alterations in both gyrA and gyrB genes. J. Antimicrob. Chemother. 32:367-377.
13. Hooper DC. 2005. Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists. Clin. Infect. Dis. 40:1811-1817.
14. Nishino K, Nikaido E, Yamaguchi A. 2009. Regulation and physiological function of multidrug efflux pumps in Escherichia coli and Salmonella. Biochim. Biophys. Acta 1794:834-843.
15. Levy SB. 1992. Active efflux mechanisms for antimicrobial resistance. Antimicrob. Agents Chemother. 36:695-703.
16. Nikaido H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
17. Alvarez-Ortega C, Olivares J, Martínez JL. 2013. RND multidrug efflux pumps: what are they good for? Front. Microbiol. 4:7.
18. Tseng TT, Gratwick KS, Kollman J, Park D, Nies DH, Goffeau A, Saier MH, Jr. 1999. The RND permease superfamily: an ancient, ubiquitous and diverse family that includes human disease and development proteins. J. Mol. Microbiol. Biotechnol. 1:107-125.
19. Lubelski J, Konings WN, Driessen AJ. 2007. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 71:463-476.
20. Pao SS, Paulsen IT, Saier MH. 1998. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62:1-34.
21. Jack DL, Yang NM, Saier MH. 2001. The drug/metabolite transporter superfamily. Eur. J. Biochem. 268:3620-3639.
22. Kuroda T, Tsuchiya T. 2009. Multidrug efflux transporters in the MATE family. Biochim. Biophys. Acta 1794:763-768.
23. Santiviago CA, Fuentes JA, Bueno SM, Trombert AN, Hildago AA, Socias LT, Youderian P, Mora GC. 2002. The Salmonella enterica sv. Typhimurium smvA, yddG and ompD (porin) genes are required for the efficient efflux of methyl viologen. Mol. Microbiol. 46:687-698.
24. Nishino K, Latifi T, Groisman EA. 2006. Virulence and drug resistance roles of multidrug efflux systems of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 59:126-141.
25. Ma D, Cook DN, Alberti M, Pon NG, Nikaido H, Hearst JE. 1995. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol. Microbiol. 16:45-55.
26. Kobayashi N, Nishino K, Yamaguchi A. 2001. Novel macrolide-specific ABC-type efflux transporter in Escherichia coli. J. Bacteriol. 183: 5639-5644.
27. Buchmeier NA, Heffron F. 1989. Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages. Infect. Immun. 57:1-7.
28. Fields PI, Swanson RV, Haidaris CG, Heffron F. 1986. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent. Proc. Natl. Acad. Sci. U. S. A. 83:5189-5193.
29. Richter-Dahlfors A, Buchan AM, Finlay BB. 1997. Murine salmonellosis studied by confocal microscopy: Salmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo. J. Exp. Med. 186:569-580.
30. Fang FC. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820-832.
31. Damiani G, Kiyotaki C, Soeller W, Sasada M, Peisach J, Bloom BR. 1980. Macrophage variants in oxygen metabolism. J. Exp. Med. 152: 808-822.
32. Goldberg M, Belkowski LS, Bloom BR. 1990. Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene. J. Clin. Invest. 85:563-569.
33. McGovern VJ, Slavutin LJ. 1979. Pathology of Salmonella colitis. Am. J. Surg. Pathol. 3:483-490.
34. Barthel M, Hapfelmeier S, Quintanilla-Martínez L, Kremer M, Rohde M, Hogardt M, Pfeffer K, Rüssmann H, Hardt WD. 2003. Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infect. Immun. 71:2839-2858.
35. Mehta A, Singh S, Ganguly NK. 1998. Role of reactive oxygen species in Salmonella Typhimurium-induced enterocyte damage. Scand. J. Gastroenterol. 33:406-414.
36. D'Autréaux B, Toledano MB. 2007. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat. Rev. Mol. Cell Biol. 8:813-824.
37. Hyslop PA, Hinshaw DB, Scraufstatter IU, Cochrane CG, Kunz S, Vosbeck K. 1995. Hydrogen peroxide as a potent bacteriostatic antibiotic: implications for host defense. Free Radic. Biol. Med. 19:31-37.
38. Buchmeier NA, Lipps CJ, So MY, Heffron F. 1993. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages. Mol. Microbiol. 7:933-936.
39. Carlsson J, Carpenter VS. 1980. The recA gene product is more important than catalase and superoxide dismutase in protecting Escherichia coli against hydrogen peroxide toxicity. J. Bacteriol. 142:319-321.
40. Seaver LC, Imlay JA. 2001. Hydrogen peroxide fluxes and compartmentalization inside growing Escherichia coli. J. Bacteriol. 183:7182-7189.
41. Seaver LC, Imlay JA. 2004. Are respiratory enzymes the primary sources of intracellular hydrogen peroxide? J. Biol. Chem. 279:48742-48750.
42. Seaver LC, Imlay JA. 2001. Alkyl hydroperoxide reductase is the primary scavenger of endogenous hydrogen peroxide in Escherichia coli. J. Bacteriol. 183:7173-7181.
43. Imlay JA. 2008. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 77:755-776.
44. Fang FC. 2011. Antimicrobial actions of reactive oxygen species. mBio 2(2):e00141-11. doi:10.1128/mBio.00141-11.
45. Clare DA, Duong MN, Darr D, Archibald F, Fridovich I. 1984. Effects of molecular oxygen on detection of superoxide radical with nitroblue tetrazolium and on activity stains for catalase. Anal. Biochem. 140: 532-537.
46. Dubern JF, Coppoolse ER, Stiekema WJ, Bloemberg GV. 2008. Genetic and functional characterization of the gene cluster directing the biosynthesis of putisolvin I and II in Pseudomonas putida strain PCL1445. Microbiology 154:2070-2083.
47. Lim SP, Roongsawang N, Washio K, Morikawa M. 2009. Flexible exportation mechanisms of arthrofactin in Pseudomonas sp. MIS38. J. Appl. Microbiol. 107:157-166.
48. Rouquette Loughlin CE, Balthazar JT, Shafer WM. 2005. Characterization of the MacA-MacB efflux system in Neisseria gonorrhoeae. J. Antimicrob. Chemother. 56:856-860.
49. Yamanaka H, Kobayashi H, Takahashi E, Okamoto K. 2008. MacAB is involved in the secretion of Escherichia coli heat-stable enterotoxin II. J. Bacteriol. 190:7693-7698.
50. Nakoneczna I, Hsu HS. 1980. The comparative histopathology of primary and secondary lesions in murine salmonellosis. Br. J. Exp. Pathol. 61:76-84.
51. Vazquez-Torres A, Xu Y, Jones-Carson J, Holden DW, Lucia SM, Dinauer MC, Mastroeni P, Fang FC. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287:1655-1658.
52. Day DW, Mandal BK, Morson BC. 1978. The rectal biopsy appearances in Salmonella colitis. Histopathology 2:117-131.
53. Nikaido E, Yamaguchi A, Nishino K. 2008. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283:24245-24253.
54. Rosenberg EY, Bertenthal D, Nilles ML, Bertrand KP, Nikaido H. 2003. Bile salts and fatty acids induce the expression of Escherichia coli AcrAB multidrug efflux pump through their interaction with Rob regulatory protein. Mol. Microbiol. 48:1609-1619.
55. Bina JE, Provenzano D, Wang C, Bina XR, Mekalanos JJ. 2006. Characterization of the Vibrio cholerae vexAB and vexCD efflux systems. Arch. Microbiol. 186:171-181.
56. Lin J, Cagliero C, Guo B, Barton YW, Maurel MC, Payot S, Zhang Q. 2005. Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J. Bacteriol. 187:7417-7424.
57. Pumbwe L, Skilbeck CA, Nakano V, Avila-Campos MJ, Piazza RM, Wexler HM. 2007. Bile salts enhance bacterial co-aggregation, bacterial-intestinal epithelial cell adhesion, biofilm formation and antimicrobial resistance of Bacteroides fragilis. Microb. Pathog. 43:78-87.
58. Hartog E, Ben-Shalom L, Shachar D, Matthews KR, Yaron S. 2008. Regulation of marA, soxS, rob, acrAB and micF in Salmonella enterica serovar Typhimurium. Microbiol. Immunol. 52:565-574.
59. Lu C, Albano CR, Bentley WE, Rao G. 2005. Quantitative and kinetic study of oxidative stress regulons using green fluorescent protein. Biotechnol. Bioeng. 89:574-587.
60. Nikaido E, Shirosaka I, Yamaguchi A, Nishino K. 2011. Regulation of the AcrAB multidrug efflux pump in Salmonella enterica serovar Typhimurium in response to indole and paraquat. Microbiology 157:648-655.
61. Gu M, Imlay JA. 2011. The SoxRS response of Escherichia coli is directly activated by redox-cycling drugs rather than by superoxide. Mol. Microbiol. 79:1136-1150.
62. Kehrenberg C, Cloeckaert A, Klein G, Schwarz S. 2009. Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS. J. Antimicrob. Chemother. 64:1175-1180.
63. Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B. 2001. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (serovar Typhimurium). Antimicrob. Agents Chemother. 45:38-43.
64. Koutsolioutsou A, Peña-Llopis S, Demple B. 2005. Constitutive soxR mutations contribute to multiple-antibiotic resistance in clinical Escherichia coli isolates. Antimicrob. Agents Chemother. 49:2746-2752.
65. Bratu S, Landman D, George A, Salvani J, Quale J. 2009. Correlation of the expression of acrB and the regulatory genes marA, soxS and ramA with antimicrobial resistance in clinical isolates of Klebsiella pneumoniae endemic to New York City. J. Antimicrob. Chemother. 64:278-283.
66. Pérez A, Poza M, Aranda J, Latasa C, Medrano FJ, Tomás M, Romero A, Lasa I, Bou G. 2012. Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae. Antimicrob. Agents Chemother. 56:6256-6266.
67. Vaisman N, Kerasin E, Hahn T, Trifon S, Voet H, Tabachnik E. 1994. Increased neutrophil chemiluminescence production in patients with cystic fibrosis. Metabolism 43:719-722.
68. Chen H, Hu J, Chen PR, Lan L, Li Z, Hicks LM, Dinner AR, He C. 2008. The Pseudomonas aeruginosa multidrug efflux regulator MexR uses an oxidation-sensing mechanism. Proc. Natl. Acad. Sci. U. S. A. 105: 13586-13591.
69. Fraud S, Poole K. 2011. Oxidative stress induction of the MexXY multidrug efflux genes and promotion of aminoglycoside resistance development in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 55: 1068-1074.
70. Galán JE, Curtiss R, III. 1989. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6:433-443.
71. Miller SI, Kukral AM, Mekalanos JJ. 1989. A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence. Proc. Natl. Acad. Sci. U. S. A. 86:5054-5058.
72. Shin D, Lee EJ, Huang H, Groisman EA. 2006. A positive feedback loop promotes transcription surge that jump-starts Salmonella virulence circuit. Science 314:1607-1609.
73. Eriksson S, Lucchini S, Thompson A, Rhen M, Hinton JC. 2003. Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol. Microbiol. 47:103-118.
74. Hautefort I, Thompson A, Eriksson-Ygberg S, Parker ML, Lucchini S, Danino V, Bongaerts RJ, Ahmad N, Rhen M, Hinton JC. 2008. During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell. Microbiol. 10: 958-984.
75. Park S, You X, Imlay JA. 2005. Substantial DNA damage from submicromolar intracellular hydrogen peroxide detected in Hpxmutants of Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 102:9317-9322.
76. Pridmore RD, Pittet AC, Praplan F, Cavadini C. 2008. Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol. Lett. 283:210-215.
77. Wentworth CC, Alam A, Jones RM, Nusrat A, Neish AS. 2011. Enteric commensal bacteria induce ERK pathway signaling via formyl peptide receptor (FPR)-dependent redox modulation of dual specific phosphatase 3 (DUSP3). J. Biol. Chem. 288:38448-38455.
78. Nathan CF. 1987. Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes. J. Clin. Invest. 80:1550-1560.
79. Datsenko KA, Wanner BL. 2000. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. U. S. A. 97:6640-6645.
80. Santiviago CA, Reynolds MM, Porwollik S, Choi SH, Long F, Andrews-Polymenis HL, McClelland M. 2009. Analysis of pools of targeted Salmonella deletion mutants identifies novel genes affecting fitness during competitive infection in mice. PLoS Pathog. 5:e1000477. doi:10.1371/ journal.ppat.1000477.
81. Bogomolnaya LM, Santiviago CA, Yang HJ, Baumler AJ, Andrews-Polymenis HL. 2008. "Form variation" of the O12 antigen is critical for persistence of Salmonella Typhimurium in the murine intestine. Mol. Microbiol. 70:1105-1119.
82. Thierauf A, Perez G, Maloy S. 2009. Bacteriophages. Generalized Transduct. 501:267-286.
83. Bajaj V, Lucas RL, Hwang C, Lee CA. 1996. Co-ordinate regulation of Salmonella typhimurium invasion genes by environmental and regulatory factors is mediated by control of hilA expression. Mol. Microbiol. 22: 703-714.
84. Galán JE, Curtiss R. 1990. Expression of Salmonella typhimurium genes required for invasion is regulated by changes in DNA supercoiling. Infect. Immun. 58:1879-1885.
85. Zhang X, Bremer H. 1995. Control of the Escherichia coli rrnB P1 promoter strength by ppGpp. J. Biol. Chem. 270:11181-11189.